How Do You Validate a Chemical Analytical Method (ICH Q2(R1))?

If you work in a pharmaceutical, clinical, or food-testing laboratory, you have probably been asked to "validate" an analytical method. But what does that actually mean, and how do you prove your method is fit for purpose?

What It Is

Chemical method validation is the documented process of demonstrating that an analytical procedure is suitable for its intended use. The authoritative framework is provided by the International Council for Harmonisation (ICH) guideline Q2(R1), Validation of Analytical Procedures: Text and Methodology, supported by relevant FDA guidance documents. Validation is a regulatory requirement for releasing products, transferring methods, and supporting stability studies.

How It Works: The ICH Q2(R1) Validation Parameters

ICH Q2(R1) defines the core performance characteristics you must evaluate. The exact set depends on the method type (e.g., identification, impurity test, assay), but the classic parameters are:

  • Accuracy – closeness of the measured value to the true value (often expressed as % recovery).
  • Precision – repeatability (same day), intermediate precision (different days/analysts), and reproducibility (inter-laboratory).
  • Linearity – ability to obtain results directly proportional to analyte concentration, usually assessed by regression analysis (correlation coefficient r ≥ 0.999 for assays).
  • Range – the interval between upper and lower analyte concentrations where accuracy and precision are demonstrated.
  • LOD (Limit of Detection) – the lowest amount of analyte detectable, not necessarily quantifiable.
  • LOQ (Limit of Quantification) – the lowest amount that can be quantified with acceptable precision and accuracy.
  • Robustness – capacity to remain unaffected by small, deliberate variations in method parameters (e.g., pH, column temperature, flow rate).


A Worked Illustrative Example

Example data (illustrative only). Suppose you are validating an HPLC assay for a drug substance. You prepare five calibration standards from 50–150% of the target concentration (100 µg/mL). Your linear regression yields:

  • Slope = 1.02, intercept = 0.5, r² = 0.9992 → linearity is acceptable.
  • You spike a placebo at 100 µg/mL in triplicate on three days. Mean recovery = 99.2%, RSD = 1.1% → accuracy and precision are within typical acceptance criteria (98–102% recovery; RSD ≤ 2%).
  • From the standard deviation of the blank (σ = 0.3 µg/mL) and the slope (S = 1.02), you calculate:

- LOD = 3.3 × σ / S = 3.3 × 0.3 / 1.02 ≈ 0.97 µg/mL
- LOQ = 10 × σ / S = 10 × 0.3 / 1.02 ≈ 2.94 µg/mL

These values confirm the method can detect and quantify trace impurities well below the 0.1% reporting threshold.

Common Pitfalls

  • Confusing LOD with LOQ – LOD is qualitative; LOQ must meet precision and accuracy targets.
  • Testing only one concentration for accuracy – ICH requires accuracy across the range (at least 3 concentrations, 3 replicates each).
  • Ignoring robustness until after validation – robustness should be assessed early, ideally during method development.
  • Using r instead of r² – report the correlation coefficient but also examine the y-intercept and residual plot for hidden bias.


Closing

A well-designed validation study following ICH Q2(R1) gives you confidence that your method generates reliable data every time. To streamline the calculations and documentation, try the free chemical method validation tool at https://www.6sq.com/tools/chemval/ – it walks you through each parameter and helps you present results in a regulatory-ready format.
Invited:

0 replies, guests cannot view replies. For more features, please log in or register